Obstructive sleep apnea (OSA) is very common in patients with Type 2 diabetes (T2D). Over the last two decades there has been increasing interest in the impact of OSA on glucose metabolism and the impact of OSA in patients with T2D, which mostly focused on the impact of OSA on glycemic measures. However, more recently the impact of OSA on diabetes-related vascular risk factors and outcomes in patients with T2D gained interest. In this article I will briefly review of the epidemiology and impact of OSA in patients with T2D with particular focus on the impact of OSA on diabetes-related outcomes such as hyperglycemia, cardiovascular disease risk factors and vascular complications.
No takes yet. Share an insight, caveat, or question.
Abd A. Tahrani (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: